Accounts Payable - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Accounts Payable Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Accounts Payable
-zł5.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Accounts Payable
zł376k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medicofarma Biotech SA
WSE:MDB
Accounts Payable
zł1.2m
CAGR 3-Years
81%
CAGR 5-Years
41%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Accounts Payable
zł32.2m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Accounts Payable?
Accounts Payable
-5.5m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Accounts Payable amounts to -5.5m PLN.

Back to Top